Leerink Upgrades Amgen (AMGN) to Outperform, 'both a multiple-expansion and earnings-upside call'
Tweet Send to a Friend
(Updated - October 11, 2023 10:41 AM EDT)
Leerink Partners analyst David Risinger upgraded Amgen (NASDAQ: AMGN) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst David Risinger upgraded Amgen (NASDAQ: AMGN) from Market ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
